Nuformix plc (NFX.L)
NFX.L Stock Price Chart
Explore Nuformix plc interactive price chart. Choose custom timeframes to analyze NFX.L price movements and trends.
NFX.L Company Profile
Discover essential business fundamentals and corporate details for Nuformix plc (NFX.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
17 Dec 2015
Employees
3.00
Website
https://www.nuformix.comCEO
Daniel John Gooding
Description
Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications. Nuformix plc was founded in 2008 and is based in London, the United Kingdom.
NFX.L Financial Timeline
Browse a chronological timeline of Nuformix plc corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 30 Apr 2026
Upcoming earnings on 27 Jan 2026
Earnings released on 2 May 2025
Earnings released on 29 Jan 2025
EPS came in at -£0.00 .
Earnings released on 18 Jun 2024
EPS came in at £0.00 .
Earnings released on 19 Mar 2024
EPS came in at -£0.00 .
Earnings released on 22 May 2023
EPS came in at -£0.00 .
Earnings released on 24 Jan 2023
EPS came in at £0.00 .
Earnings released on 28 Jul 2022
EPS came in at -£0.00 .
Earnings released on 14 Dec 2021
EPS came in at -£0.00 , while revenue for the quarter reached £50.00K .
Earnings released on 15 Jul 2021
EPS came in at -£0.00 .
Earnings released on 22 Dec 2020
EPS came in at -£0.00 , while revenue for the quarter reached £195.55K .
NFX.L Stock Performance
Access detailed NFX.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.